We are live on ! Find out more
TA

Tamarack Advisers Portfolio holdings

AUM $2.12M
1-Year Est. Return 58.09%
This Fund
S&P 500
This Quarter Est. Return
-8.03%
1 Year Est. Return
-58.09%
3 Year Est. Return
-46.51%
5 Year Est. Return
+44.44%
10 Year Est. Return
–
AUM
$141M
AUM Growth
-$177M
Cap. Flow
-$170M
Cap. Flow %
-120.04%
Top 10 Hldgs %
60.47%
Holding
47
New
9
Increased
2
Reduced
14
Closed
20

Top Buys

1
GILD icon
Gilead Sciences
GILD
+$7.43M
2
LH icon
Labcorp
LH
+$6.59M
3
AMGN icon
Amgen
AMGN
+$4.67M
4
ATHN
Athenahealth, Inc.
ATHN
+$4.41M
5
IPXL
Impax Laboratories, Inc.
IPXL
+$4.4M

Top Sells

1
ELGX
Endologix Inc
ELGX
+$35.7M
2
PDCO
Patterson Companies, Inc.
PDCO
+$24.7M
3
NXTM
NxStage Medical Inc.
NXTM
+$17.5M
4
WBA
Walgreens Boots Alliance
WBA
+$16M
5
ARIA
Ariad Pharmaceuticals Inc
ARIA
+$12M

Sector Composition

1 Healthcare 92.03%
2 Industrials 3.05%
3 Consumer Discretionary 2.51%
4 Communication Services 0%
5 Real Estate 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HSIC icon
26
Henry Schein
HSIC
$9.98B
$164K 0.12%
+918
New +$55.4K
SYK icon
27
Stryker
SYK
$123B
$27K 0.02%
+250
New +$28.8K
ATRC icon
28
AtriCure
ATRC
$1.79B
– –
-135,000
Closed -$2.1M
BSX icon
29
PUT
Boston Scientific
BSX
$65.2B
– –
-3,500
Closed -$533K
DGX icon
30
Quest Diagnostics
DGX
$23.3B
– –
-8,557
Closed -$716K
GKOS icon
31
Glaukos
GKOS
$9.12B
– –
-45,000
Closed -$1.72M
LNTH icon
32
Lantheus
LNTH
$6.86B
– –
-28,047
Closed -$226K
MDT icon
33
Medtronic
MDT
$106B
– –
-115,000
Closed -$9.88M
OEF icon
34
PUT
iShares S&P 100 ETF
OEF
$20.2B
– –
-3,000
Closed -$372K
OPCH icon
35
Option Care Health
OPCH
$3.42B
– –
-208,713
Closed -$2.45M
SPY icon
36
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$777B
– –
-5,000
Closed -$520K
WBA
37
DELISTED
Walgreens Boots Alliance
WBA
– –
-200,000
Closed -$16M
XLV icon
38
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$41.5B
– –
-1,000
Closed -$253K
PDCO
39
DELISTED
Patterson Companies, Inc.
PDCO
– –
-545,000
Closed -$24.7M
MODN
40
DELISTED
MODEL N, INC.
MODN
– –
-335,000
Closed -$3.63M
ENDP
41
DELISTED
Endo International plc
ENDP
– –
-75,000
Closed -$1.52M
ARA
42
DELISTED
American Renal Associates Holdings, Inc
ARA
– –
-100,000
Closed -$1.77M
INSY
43
CALL
DELISTED
Insys Therapeutics, Inc.
INSY
– –
-2,010
Closed -$366K
MRT
44
DELISTED
MedEquities Realty Trust, Inc.
MRT
– –
-150,000
Closed -$1.77M
ELGX
45
DELISTED
Endologix Inc
ELGX
– –
-288,650
Closed -$35.7M
ATHN
46
CALL
DELISTED
Athenahealth, Inc.
ATHN
– –
-900
Closed -$1.67M
1
2

Similar funds

SCM
SevenOneSeven Capital Management Lancaster, Pennsylvania $2.17M AUM 8.67% 1-Year Est. Return
LBC
Lawrence B. Cohen $2.06M AUM 34.47% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
LCMP
Linse Capital Management PR San Juan, Puerto Rico $2.31M AUM
GIP
General Industrial Partners London, United Kingdom $2.57M AUM
STC
Sarah T. Connolly $1.11M AUM 24.13% 1-Year Est. Return
GC
Gilfoyle & Co San Francisco, California $671K AUM
DU
Delphia (USA) Toronto, Ontario, Canada $445K AUM 28.82% 1-Year Est. Return

Tamarack Advisers's Q4 2016 Portfolio in Review

As of Q4 2016, Tamarack Advisers held 47 positions worth $141M, down 56% from $318M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Tamarack Advisers withdrew a net $170M in Q4 2016, closing 20 positions and reducing 14 holdings. Its most notable exit was Endologix Inc, an estimated $35.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, up from 85% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Tamarack Advisers opened a new position in Gilead Sciences worth $7.16M.

  • Tamarack Advisers's largest Q4 2016 buy was Gilead Sciences: 100,000 shares worth $7.16M.
  • Tamarack Advisers added most to Teladoc Health in Q4 2016, an estimated $1.54M increase.
  • Tamarack Advisers's biggest Q4 2016 reduction was NxStage Medical Inc., cutting an estimated $17.5M.
  • Tamarack Advisers fully exited Endologix Inc in Q4 2016, selling an estimated $35.7M.
  • Tamarack Advisers's ten largest holdings make up 60% of its $141M portfolio in Q4 2016.
  • Tamarack Advisers opened 9 new positions and closed 20 in Q4 2016.
  • Tamarack Advisers's portfolio value fell 56% quarter-over-quarter to $141M.

Based on Tamarack Advisers's 13F filing for Q4 2016, filed 14 Feb 2017.